News

The European Council needs to decide in June where the EMA will relocate after Brexit. If not its “well-oiled” machinery could stall and the safety of medicines be put at risk

After treating only one person with the ground-breaking therapy, uniqure is giving up on Glybera and shifting all its commercial manufacturing to the US

The UK’s world-leading higher education sector risks a brain drain post-Brexit. A cross-party group of MPs says uncertainties for staff and students should be removed immediately

The March for Science was an unprecedented show of solidarity and protest against the rise of “anti-science” and alternative facts. Back in the lab, here are some suggestions for how the momentum can be maintained

There is general recognition healthcare systems need to shift from paying for volume to paying for outcomes, but this is a difficult change to make. A new incentive system in France for funding remote monitoring of chronic diseases, points the way

Some stroke survivors say they are disregarding general practitioners' (GP) advice on secondary prevention medications, such as statins, with some patients stopping their medication completely, according to a study of an online stroke forum